Prevalence of Depression and Sleep Disorders in Patients on Dialysis: A Cross-Sectional Study in Qatar

Patients with end-stage renal disease treated with dialysis have poor quality of life (QOL). Improving QOL in these patients with multiple comorbidities is a large challenge. We performed a cross-sectional study to evaluate the prevalence and associated factors of depression and sleep disorders in t...

Full description

Saved in:
Bibliographic Details
Main Authors: Fadwa Al-Ali, Mostafa Elshirbeny, Abdullah Hamad, Ahmad Kaddourah, Tarek Ghonimi, Rania Ibrahim, Tarek Fouda
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:International Journal of Nephrology
Online Access:http://dx.doi.org/10.1155/2021/5533416
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566145400438784
author Fadwa Al-Ali
Mostafa Elshirbeny
Abdullah Hamad
Ahmad Kaddourah
Tarek Ghonimi
Rania Ibrahim
Tarek Fouda
author_facet Fadwa Al-Ali
Mostafa Elshirbeny
Abdullah Hamad
Ahmad Kaddourah
Tarek Ghonimi
Rania Ibrahim
Tarek Fouda
author_sort Fadwa Al-Ali
collection DOAJ
description Patients with end-stage renal disease treated with dialysis have poor quality of life (QOL). Improving QOL in these patients with multiple comorbidities is a large challenge. We performed a cross-sectional study to evaluate the prevalence and associated factors of depression and sleep disorders in this population. Our primary aim was to evaluate QOL measures in dialysis patients in Qatar through a series of validated questionnaires mainly concerning depression and sleep disorders. Our secondary aim was to study the associations of age, sex, and comorbid conditions with the QOL measures. We hypothesized that end-stage renal disease (ESRD) patients on dialysis would have disturbed QOL due to both ESRD and dialysis and comorbidities. This prospective cross-sectional study included adult ESRD patients receiving either hemodialysis (HD) or peritoneal dialysis (PD) in the main tertiary dialysis unit in Qatar. We administered two surveys to evaluate depression (the Center for Epidemiologic Studies Depression Scale, http://www.bmedreport.com/archives/7139) and sleep disorders (the Pittsburgh Sleep Quality Index, https://www.sleep.pitt.edu/instruments/). We also reviewed patient demographics, comorbidities, and laboratory test results to evaluate any associated factors. We randomly studied 253 patients (62% on HD and 38% on PD). Overall, 48% of patients had depression, while 83.8% had sleep disorders. The PD had more poor sleepers than the HD group (89.1% versus (vs.) 75%, p=0.003). Most of our dialysis patients had poor sleep, but it was more significant in the elderly group 109 (90%) than in the young group 103 (78%) (p=0.009). Patients with diabetes mellitus (DM) had significantly more prevalence of poor sleep (131 (88.5%)) than those without DM (81 (77.1%), p=0.01). More female patients had depression than male patients (52% vs. 25%, p<0.0001; odds ratio: 3.27 (95% confidence interval: 1.9–5.6), p<0.0001). This is the first study in Qatar to evaluate depression and sleep disorders in patients on dialysis therapy.
format Article
id doaj-art-8d7622b30d474b3188069e7b4f4768cf
institution Kabale University
issn 2090-214X
2090-2158
language English
publishDate 2021-01-01
publisher Wiley
record_format Article
series International Journal of Nephrology
spelling doaj-art-8d7622b30d474b3188069e7b4f4768cf2025-02-03T01:05:05ZengWileyInternational Journal of Nephrology2090-214X2090-21582021-01-01202110.1155/2021/55334165533416Prevalence of Depression and Sleep Disorders in Patients on Dialysis: A Cross-Sectional Study in QatarFadwa Al-Ali0Mostafa Elshirbeny1Abdullah Hamad2Ahmad Kaddourah3Tarek Ghonimi4Rania Ibrahim5Tarek Fouda6Department of Nephrology, Hamad Medical Corporation, Doha, ZIP/Post Code 3050, QatarDepartment of Nephrology, Hamad Medical Corporation, Doha, ZIP/Post Code 3050, QatarDepartment of Nephrology, Hamad Medical Corporation, Doha, ZIP/Post Code 3050, QatarDepartment of Nephrology, Hamad Medical Corporation, Doha, ZIP/Post Code 3050, QatarDepartment of Nephrology, Hamad Medical Corporation, Doha, ZIP/Post Code 3050, QatarDepartment of Nephrology, Hamad Medical Corporation, Doha, ZIP/Post Code 3050, QatarDepartment of Nephrology, Hamad Medical Corporation, Doha, ZIP/Post Code 3050, QatarPatients with end-stage renal disease treated with dialysis have poor quality of life (QOL). Improving QOL in these patients with multiple comorbidities is a large challenge. We performed a cross-sectional study to evaluate the prevalence and associated factors of depression and sleep disorders in this population. Our primary aim was to evaluate QOL measures in dialysis patients in Qatar through a series of validated questionnaires mainly concerning depression and sleep disorders. Our secondary aim was to study the associations of age, sex, and comorbid conditions with the QOL measures. We hypothesized that end-stage renal disease (ESRD) patients on dialysis would have disturbed QOL due to both ESRD and dialysis and comorbidities. This prospective cross-sectional study included adult ESRD patients receiving either hemodialysis (HD) or peritoneal dialysis (PD) in the main tertiary dialysis unit in Qatar. We administered two surveys to evaluate depression (the Center for Epidemiologic Studies Depression Scale, http://www.bmedreport.com/archives/7139) and sleep disorders (the Pittsburgh Sleep Quality Index, https://www.sleep.pitt.edu/instruments/). We also reviewed patient demographics, comorbidities, and laboratory test results to evaluate any associated factors. We randomly studied 253 patients (62% on HD and 38% on PD). Overall, 48% of patients had depression, while 83.8% had sleep disorders. The PD had more poor sleepers than the HD group (89.1% versus (vs.) 75%, p=0.003). Most of our dialysis patients had poor sleep, but it was more significant in the elderly group 109 (90%) than in the young group 103 (78%) (p=0.009). Patients with diabetes mellitus (DM) had significantly more prevalence of poor sleep (131 (88.5%)) than those without DM (81 (77.1%), p=0.01). More female patients had depression than male patients (52% vs. 25%, p<0.0001; odds ratio: 3.27 (95% confidence interval: 1.9–5.6), p<0.0001). This is the first study in Qatar to evaluate depression and sleep disorders in patients on dialysis therapy.http://dx.doi.org/10.1155/2021/5533416
spellingShingle Fadwa Al-Ali
Mostafa Elshirbeny
Abdullah Hamad
Ahmad Kaddourah
Tarek Ghonimi
Rania Ibrahim
Tarek Fouda
Prevalence of Depression and Sleep Disorders in Patients on Dialysis: A Cross-Sectional Study in Qatar
International Journal of Nephrology
title Prevalence of Depression and Sleep Disorders in Patients on Dialysis: A Cross-Sectional Study in Qatar
title_full Prevalence of Depression and Sleep Disorders in Patients on Dialysis: A Cross-Sectional Study in Qatar
title_fullStr Prevalence of Depression and Sleep Disorders in Patients on Dialysis: A Cross-Sectional Study in Qatar
title_full_unstemmed Prevalence of Depression and Sleep Disorders in Patients on Dialysis: A Cross-Sectional Study in Qatar
title_short Prevalence of Depression and Sleep Disorders in Patients on Dialysis: A Cross-Sectional Study in Qatar
title_sort prevalence of depression and sleep disorders in patients on dialysis a cross sectional study in qatar
url http://dx.doi.org/10.1155/2021/5533416
work_keys_str_mv AT fadwaalali prevalenceofdepressionandsleepdisordersinpatientsondialysisacrosssectionalstudyinqatar
AT mostafaelshirbeny prevalenceofdepressionandsleepdisordersinpatientsondialysisacrosssectionalstudyinqatar
AT abdullahhamad prevalenceofdepressionandsleepdisordersinpatientsondialysisacrosssectionalstudyinqatar
AT ahmadkaddourah prevalenceofdepressionandsleepdisordersinpatientsondialysisacrosssectionalstudyinqatar
AT tarekghonimi prevalenceofdepressionandsleepdisordersinpatientsondialysisacrosssectionalstudyinqatar
AT raniaibrahim prevalenceofdepressionandsleepdisordersinpatientsondialysisacrosssectionalstudyinqatar
AT tarekfouda prevalenceofdepressionandsleepdisordersinpatientsondialysisacrosssectionalstudyinqatar